Injection Pen Market Research Report – Forecast to 2023

Global Injection Pen Market Research Report: By Type (Disposable Injection Pens, Others), by Product (Insulin Pens, Pen Needles), by Therapy (Diabetes, Others), by Distribution Channel (Hospital Pharmacies, Others), by End-User – Global Forecast Till 2023

ID: MRFR/MED/4688-HCR | February 2021 | Region: Global | 100 pages

Market Scenario


The global injection pen market is expected to gain prominence over the forecast period (2018–2023). It is estimated that the global injection pen market is expected to register at a CAGR ~ 6.5 % during the forecast period of 2018–2023.


Injection pens are designed to deliver the drug in the body with ease and convenience. It is a small, hand-held portable device used to inject drug for the treatment of various diseases. The increasing occurrences of chronic diseases such as diabetes and osteoporosis globally are expected to drive the global injection pen market during the forecast period. For instance, in 2015, according to the American Diabetes Association, 30.3 million people in the U.S. had diabetes which is 9.4% of the total population. Moreover, the growing preference of injection pens over the traditional vial and syringe method owing to the increasing cases of needlestick injuries is likely to contribute to the market growth.


Despite the drivers, factors such as reimbursement issues in developing countries and preference of alternative drug delivery modes are restraining the growth of the global injection pen market.


Segmentation


The global injection pen market is segmented on the basis of type, product, therapy, distribution channel, and end-user.


On the basis of type, the market is classified into disposable injection pens and reusable injection pens.


The global injection pen market on the basis of product is segmented into insulin pens and pen needles.


On the basis of therapy, the market is segmented as diabetes, growth hormone therapy, fertility, osteoporosis, multiple sclerosis, cardiovascular diseases, rheumatoid arthritis, obesity, Crohn’s disease, cancer, and others. Diabetes is further segmented into insulin and GLP-1.


On the basis of distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, online medical stores, and diabetes clinics.


On the basis of end-user, the global injection pen market is segmented into home care and hospitals and clinics.


Geographically, the market has been segmented into America, Europe, Asia Pacific, and the Middle East and Africa. The American injection pen market is further segmented into North America and South America. North America is further classified as the U.S. and Canada.


The Europe injection pen market is segmented into Western Europe and Eastern Europe. Western Europe is further classified as Germany, France, the U.K., Italy, Spain, and the rest of Western Europe. 


The Asia Pacific injection pen market is segmented into Japan, China, India, Republic of Korea, Australia, and the rest of Asia Pacific.


The Middle Eastern and African injection pen market is segmented into the Middle East and Africa.


Regional Market Summary


Global Injection Pen Market, by Region Market Share, 2017 (%)


 Injection Pen Market


Source: MRFR Analysis


The Americas is likely to dominate the global injection pen market owing to the increasing prevalence of diabetes and cancer, increasing number of approvals, and subsequent launches of new products during the forecast period. For instance, as per the National Diabetes Statistics Report 2014, 29.1 million people, i.e., 9.3% of the America population had diabetes. Furthermore, continuous development of advanced injection pens by manufacturers in the region contributes to the market growth.


Europe is likely to hold the second position in the global injection pen market. It is expected that the well-developed healthcare sector and increasing prevalence of chronic diseases in this region are likely to drive the market. Additionally, according to WHO, there are 3.7 million cases of cancer in Europe every year.  Furthermore, favorable government policies for research have attracted many of the prominent market players.


Asia Pacific is the fastest growing region in the market owing to the huge patient population with chronic diseases. According to WHO, 60% of the world's diabetic population lives in Asia Pacific. This is the major factor responsible for the fastest growth of the injection pen market in this region. Additionally, according to a study published in the Asian Pacific Journal of Tropical Biomedicine Journal in 2014, it was estimated that about 150 million diabetic patients reside within the region, out of which more than 95% have type 2 diabetes mellitus. Furthermore, rapid developments in the economies and increasing healthcare expenditure have fueled the growth of the market.


The Middle East and Africa accounts for the lowest market share in the global injection pen market. However, some prominent key players are investing in the Middle Eastern region which is likely to contribute to the growth of the market during the forecast period. For instance, in September 2015, Novo Nordisk invested 7.8 million USD for building manufacturing plants in Iran for the production of FlexPen Prefilled insulin device.


Key Players


Some of the key players in the global injection pen market are  Novo Nordisk (Denmark), Eli Lilly (U.S.), Sanofi (France), Merck (U.S.), Ypsomed (Switzerland), AstraZeneca (U.K.), F.Hoffman-La Roche (Switzerland), Becton Dickinson and Company (U.S.), Owen Mumford (U.K.), Novartis (Switzerland), Pfizer (U.S.), Haselmeier (Switzerland), Jiangsu Delfu medical device Co. Ltd (China), and Biocon Ltd (India).


Research Methodology


Market Research Future research is conducted by industry experts who offer insight into industry structure, market segmentation, Treatment assessment, Competitive Landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research (~ 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years, by analyzing historical trends and current market positions. Furthermore, the varying trends of segments & categories geographically presented are studied and are estimated based on primary & secondary research.



  • Primary Research


The extensive primary research was conducted to gain a deeper insight into the market and the industry performance. In this particular report, we have conducted primary surveys (interviews) with the key level executives (VP, CEO's, Marketing Director, Business Development Manager and many more) of the major players who are active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed, over the next five to ten years.



  • Secondary Research


Secondary research was mainly used to collect and identify information useful for an extensive, technical, market-oriented, and commercial study of the global injection pen market. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, & developments related to the market and Treatment Perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, SEC filings, journals, white papers, corporate presentations, company websites, the international organization of chemical manufacturers, some paid databases, and many others.


Global Injection Pen Market, by Type



  • Disposable injection pens

  • Reusable injection pens


Global Injection Pen Market, by Product



  • Insulin Pens

  • Pen Needles


Global Injection Pen Market, by Therapy



  • Diabetes

  • Insulin

  • GLP-1

  • Growth hormone therapy

  • Fertility

  • Osteoporosis

  • Multiple sclerosis

  • Cardiovascular diseases

  • Rheumatoid arthritis

  • Obesity

  • Crohn's disease

  • Cancer

  • Others


Global Injection Pen Market, by Distribution Channel



  • Hospital Pharmacies

  • Retail Pharmacies

  • Online Medical Stores

  • Diabetes Clinics


Global Injection pen Market, by End-User



  • Home care

  • Hospital & Clinics


Global Injection Pen Market, by Region



  • Americas

  • North America

  • U.S.

  • Canada

  • South America

  • Europe

  • Western Europe

  • Germany

  • France

  • Italy

  • Spain

  • U.K.

  • Rest of Western Europe

  • Eastern Europe

  • Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • Republic of Korea

  • Rest of Asia Pacific

  • The Middle East & Africa

  • Middle East

  • Africa


Company Profiles             



  • Novo Nordisk

  • Eli Lilly

  • Sanofi

  • Merck

  • Ypsomed

  • AstraZeneca

  • Hoffman-La Roche

  • Becton Dickinson and Company

  • Owen Mumford

  • Novartis

  • Pfizer

  • Haselmeier

  • Jiangsu Delfu medical device Co., Ltd

  • Biocon Ltd


Intended Audience



  • Injection pen manufacturing companies

  • Original equipment manufacturing companies

  • Suppliers and distributors of injection pen

  • Healthcare service providers

  • Teaching hospitals and academic medical centers

  • Health insurance players

  • Government bodies/municipal corporations

  • Regulatory bodies

  • Medical research institutes



Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Injection Pen Market, by Type

6.1 Introduction

6.2 Disposable Injection pens

Market Estimates & Forecast, by region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.3 Reusable injection pens

Market Estimates & Forecast, by region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

Chapter 7. Global Injection Pen Market, by Product

7.1 Introduction

7.2 Insulin Pens

Market Estimates & Forecast, by region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.3 Pen Needles

Market Estimates & Forecast, by region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

Chapter 8. Global Injection Pen Market, by Therapy

8.1 Introduction

8.2 Diabetes

8.2.1 Insulin

Market Estimates & Forecast, by region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.2.2 GLP - 1

Market Estimates & Forecast, by region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.3 Growth Hormone Therapy

Market Estimates & Forecast, by region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.4 Fertility

Market Estimates & Forecast, by region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.5 Osteoporosis

Market Estimates & Forecast, by region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.6 Multiple Sclerosis

Market Estimates & Forecast, by region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.7 Cardiovascular diseases

Market Estimates & Forecast, by region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.8 Rheumatoid Arthritis

Market Estimates & Forecast, by region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.9 Obesity

Market Estimates & Forecast, by region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.10 Crohn’s disease

Market Estimates & Forecast, by region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.11 Cancer

Market Estimates & Forecast, by region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.12 Others

Market Estimates & Forecast, by region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

Chapter 9. Global Injection Pen Market, by Distribution Channel

9.1 Introduction

9.2 Hospital Pharmacies

Market Estimates & Forecast, by region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

9.3 Retail Pharmacies

Market Estimates & Forecast, by region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

9.4 Online Medical Stores

Market Estimates & Forecast, by region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

9.5 Diabetes Clinics

Market Estimates & Forecast, by region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

Chapter 10. Global Injection Pen Market, by End-Users

10.1 Introduction

10.2 Homecare

Market Estimates & Forecast, by region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

10.3 Hospital & Clinics

Market Estimates & Forecast, by region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

Chapter 11. Global Injection Pen Market, by Region

11.1 Introduction

11.2 Americas

11.2.1 North America

11.2.1.1 U.S.

11.2.1.2 Canada

11.2.2 South America

11.3 Europe

11.3.1 Western Europe

11.3.1.1 Germany

11.3.1.2 France

11.3.1.3 Italy

11.3.1.4 Spain

11.3.1.5 U.K.

11.3.1.6 Rest of Western Europe

11.3.2 Eastern Europe

11.4 Asia Pacific

11.4.1 Japan

11.4.2 China

11.4.3 India

11.4.4 Australia

11.4.5 Republic of Korea

11.4.6 Rest of Asia Pacific

11.5 The Middle East & Africa

11.5.1 The Middle East

11.5.2 Africa

Chapter 12. Company Landscape

12.1 Introduction

12.2 Market Share Analysis

12.3 Key Development & Strategies

Chapter 13. Company Profiles

13.1 Novo Nordisk

13.1.1 Company Overview

13.1.2 Product Overview

13.1.3 Financials Overview

13.1.4 Key Developments

13.1.5 SWOT Analysis

13.2 Eli Lilly

13.2.1 Company Overview

13.2.2 Product Overview

13.2.3 Financial Overview

13.2.4 Key Developments

13.2.5 SWOT Analysis

13.3 Sanofi

13.3.1 Company Overview

13.3.2 Product Overview

13.3.3 Financial Overview

13.3.4 Key Development

13.3.5 SWOT Analysis

13.4 Merck

13.4.1 Company Overview

13.4.2 Technology/Business Segment Overview

13.4.3 Financial Overview

13.4.4 Key Development

13.4.5 SWOT Analysis

13.5 Ypsomed

13.5.1 Company Overview

13.5.2 Product Overview

13.5.3 Financial overview

13.5.4 Key Developments

13.5.5 SWOT Analysis

13.6 AstraZeneca

13.6.1 Company Overview

13.6.2 Product Overview

13.6.3 Financial Overview

13.6.4 Key Developments

13.6.5 SWOT Analysis

13.7 F. Hoffman-La Roche

13.7.1 Overview

13.7.2 Product Overview

13.7.3 Financial Overview

13.7.4 Key Developments

13.7.5 SWOT Analysis

13.8 Becton Dickinson and Company

13.8.1 Overview

13.8.2 Product/ Technology Overview

13.8.3 Financials

13.8.4 Key Developments

13.8.5 SWOT Analysis

13.9 Owen Mumford

13.9.1 Overview

13.9.2 Product Overview

13.9.3 Financials

13.9.4 Key Developments

13.9.5 SWOT Analysis

13.10 Novartis

13.10.1 Overview

13.10.2 Product Overview

13.10.3 Financials

13.10.4 Key Developments

13.10.5 SWOT Analysis

13.11 Pfizer

13.11.1 Overview

13.11.2 Product Overview

13.11.3 Financials

13.11.4 Key Developments

13.11.5 SWOT Analysis

13.12 Haselmeier

13.12.1 Overview

13.12.2 Product Overview

13.12.3 Financials

13.12.4 Key Developments

13.12.5 SWOT Analysis

13.13 Jiangsu Delfu medical device Co., Ltd

13.13.1 Overview

13.13.2 Product Overview

13.13.3 Financials

13.13.4 Key Developments

13.13.5 SWOT Analysis

31.14 Biocon Ltd

13.14.1 Overview

13.14.2 Product Overview

13.14.3 Financials

13.14.4 Key Developments

13.14.5 SWOT Analysis

Chapter 14 MRFR Conclusion

14.1 Key Findings

14.1.1 From CEO’s View Point

14.1.2 Unmet Needs of the Market

14.2 Key Companies to Watch

14.3 Prediction of the Arthroscopy Instruments Industry

Chapter 15 Appendix

LIST OF TABLES

Table 1 Global Injection Pen Market Synopsis, 2018–2023

Table 2 Global Injection Pen Market Estimates and Forecast, 2018–2023, (USD Million)

Table 3 Global Injection Pen Market, by Region, 2018–2023, (USD Million)

Table 4 Global Injection Pen Market, by Type, 2018–2023, (USD Million)

Table 5 Global Injection Pen Market, by Product, 2018–2023, (USD Million)

Table 6 Global Injection Pen Market, by Therapy, 2018–2023, (USD Million)

Table 7 Global Injection Pen Market, by Distribution Channel, 2018–2023, (USD Million)

Table 8 Global Injection Pen Market, by End-User, 2018–2023, (USD Million)

Table 9 North America Global Injection Pen Market, by Type, 2018–2023, (USD Million)

Table 10 North America Global Injection Pen Market, by Product, 2018–2023, (USD Million)

Table 11 North America Global Injection Pen Market, by Therapy, 2018–2023, (USD Million)

Table 12 North America Global Injection Pen Market, by Product, 2018–2023, (USD Million)

Table 13 North America Global Injection Pen Market, by Distribution Channel, 2018–2023, (USD Million)

Table 14 North America Global Injection Pen Market, by End-User, 2018–2023, (USD Million)

Table 15 U.S. Injection Pen Market, by Type, 2018–2023, (USD Million)

Table 16 U.S. Injection Pen Market, by Product, 2018–2023, (USD Million)

Table 17 U.S. Injection Pen Market, by Therapy, 2018–2023, (USD Million)

Table 18 U.S. Injection Pen Market, by Distribution Channel, 2018–2023, (USD Million)

Table 19 U.S. Injection Pen Market, by End-User, 2018–2023, (USD Million)

Table 20 Canada Injection Pen Market, by Type, 2018–2023, (USD Million)

Table 21 Canada Injection Pen Market, by Product, 2018–2023, (USD Million)

Table 22 Canada Injection Pen Market, by Therapy, 2018–2023, (USD Million)

Table 23 Canada Injection Pen Market, by Distribution Channel, 2018–2023, (USD Million)

Table 24 Canada Injection Pen Market, by End-User, 2018–2023, (USD Million)

Table 25 South America Injection Pen Market, by Type, 2018–2023, (USD Million)

Table 26 South America Injection Pen Market, by Product, 2018–2023, (USD Million

Table 27 South America Injection Pen Market, by Therapy, 2018–2023, (USD Million)

Table 28 South America Injection Pen Market, by Distribution Channel, 2018–2023, (USD Million)

Table 29 South America Injection Pen Market, by End-User, 2018–2023, (USD Million)

Table 30 Europe Injection Pen Market, by Type, 2018–2023, (USD Million)

Table 31 Europe Injection Pen Market, by Product, 2018–2023, (USD Million)

Table 32 Europe Injection Pen Market, by Therapy, 2018–2023, (USD Million)

Table 33 Europe Injection Pen Market, by Distribution Channel, 2018–2023, (USD Million)

Table 34 Europe Injection Pen Market, by End-User, 2018–2023, (USD Million)

Table 35 Western Europe Injection Pen Market, by Type, 2018–2023, (USD Million)

Table 36 Western Europe Injection Pen Market, by Product, 2018–2023, (USD Million)

Table 37 Western Europe Injection Pen Market, by Therapy, 2018–2023, (USD Million)

Table 38 Western Europe Injection Pen Market, by Distribution Channel, 2018–2023, (USD Million)

Table 39 Western Europe Injection Pen Market, by End-User, 2018–2023, (USD Million)

Table 40 Eastern Europe Injection Pen Market, by Type, 2018–2023, (USD Million)

Table 41 Eastern Europe Injection Pen Market, by Product, 2018–2023, (USD Million)

Table 42 Eastern Europe Injection Pen Market, by Therapy, 2018–2023, (USD Million)

Table 43 Eastern Europe Injection Pen Market, by Distribution Channel, 2018–2023, (USD Million)

Table 44 Eastern Europe Injection Pen Market, by End-User, 2018–2023, (USD Million)

Table 45 Asia Pacific Injection Pen Market, by Type, 2018–2023, (USD Million)

Table 46 Asia Pacific Injection Pen Market, by Product, 2018–2023, (USD Million)

Table 47 Asia Pacific Injection Pen Market, by Therapy, 2018–2023, (USD Million)

Table 48 Asia Pacific Injection Pen Market, by Distribution Channel, 2018–2023, (USD Million)

Table 49 Asia Pacific Injection Pen Market, by End-User, 2018–2023, (USD Million)

Table 50 Middle East & Africa Injection Pen Market, by Type, 2018–2023, (USD Million)

Table 51 Middle East & Africa Injection Pen Market, by Product 2018–2023, (USD Million)

Table 52 Middle East & Africa Injection Pen Market, by Therapy, 2018–2023, (USD Million)

Table 53 Middle East & Africa Injection Pen Market, by Distribution Channel, 2018–2023, (USD Million)

Table 54 Middle East & Africa Injection Pen Market, by End-User, 2018–2023, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Injection Pen Market

Figure 3 Segmentation Market Dynamics for Global Injection Pen Market

Figure 4 Global Injection Pen Market Share, by Type 2017

Figure 5 Global Injection Pen Market Share, by Product 2017

Figure 6 Global Injection Pen Market Share, by Therapy 2017

Figure 7 Global Injection Pen Market Share, by Distribution Channel 2017

Figure 8 Global Injection Pen Market Share, by End-User, 2017

Figure 9 Global Injection Pen Market Share, by Region, 2017

Figure 10 North America Injection Pen Market Share, by Country, 2017

Figure 11 Europe Injection Pen Market Share, by Country, 2017

Figure 12 Asia Pacific Injection Pen Market Share, by Country, 2017

Figure 13 Middle East & Africa Injection Pen Market Share, by Country, 2017

Figure 14 Global Injection Pen Market: Company Share Analysis, 2017 (%)

Figure 15 Novo Nordisk: Key Financials

Figure 16 Novo Nordisk: Segmental Revenue

Figure 17 Novo Nordisk: Geographical Revenue

Figure 18 Eli Lilly: Key Financials

Figure 19 Eli Lilly: Segmental Revenue

Figure 20 Eli Lilly: Geographical Revenue

Figure 21 Sanofi::Key Financials

Figure 22 Sanofi: Segmental Revenue

Figure 23 Sanofi: Geographical Revenue

Figure 24 Merck: Key Financials

Figure 25 Merck: Segmental Revenue

Figure 26 Merck: Geographical Revenue

Figure 27 Ypsomed: Key Financials

Figure 28 Ypsomed: Segmental Revenue

Figure 29 Ypsomed. Geographical Revenue

Figure 30 AstraZeneca: Key Financials

Figure 31 AstraZeneca: Segmental Revenue

Figure 32 AstraZeneca: Geographical Revenue

Figure 33 F. Hoffman- La Roche: Key Financials

Figure 34 F. Hoffman- La Roche: Segmental Revenue

Figure 35 F. Hoffman- La Roche: Geographical Revenue

Figure 36 Becton Dickinson and Company: Key Financials

Figure 37 Becton Dickinson and Company: Segmental Revenue

Figure 38 Becton Dickinson and Company: Geographical Revenue

Figure 39 Owen Mumford: Key Financials

Figure 40 Owen Mumford: Segmental Revenue

Figure 41 Owen Mumford: Geographical Revenue

Figure 42 Novartis: Key Financials

Figure 43 Novartis: Segmental Revenue

Figure 44 Novartis: Geographical Revenue

Figure 45 Pfizer: Key Financials

Figure 46 Pfizer Segmental Revenue

Figure 47 Pfizer: Geographical Revenue

Figure 48 Haselmeier: Key Financials

Figure 49 Haselmeier: Segmental Revenue

Figure 50 Haselmeier: Geographical Revenue

Figure 51 Jiangsu Delfu Co. Ltd: Key Financials

Figure 52 Jiangsu Delfu Co. Ltd: Segmental Revenue

Figure 53 Jiangsu Delfu Co. Ltd: Geographical Revenue

Figure 54 Biocon Ltd: Key Financials

Figure 55 Biocon Ltd: Segmental Revenue

Figure 56 Biocon Ltd: Geographical Revenue